Wide Ranks

CALC

CalciMedica, Inc.

3.44

Top Statistics
Market Cap 46 M Forward PE -2.11 Revenue Growth 0.00 %
Current Ratio 5.22 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.7990 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 19 M Total Cash Per Share 1.78 Total Debt
Total Debt To Equity Current Ratio 5.22 Book Value Per Share 1.42
All Measures
Short Ratio 168.00 % Message Board Id finmb_34235142 Shares Short Prior Month 37691
Return On Equity -0.8376 City La Jolla Uuid 1dade7b1-4e24-37e4-9b8f-e0dde73c0e11
Previous Close 3.39 First Trade Date Epoch Utc 1 B Book Value 1.42
Volume 22439 Price To Book 2.43 Fifty Two Week Low 2.68
Total Cash Per Share 1.78 Shares Short Previous Month Date 1 B Target Median Price 16.00
Audit Risk 10 Max Age 86400 Recommendation Mean 1.33
Sand P52 Week Change 0.3133 Target Mean Price 17.00 Net Income To Common -12589000
Short Percent Of Float 0.0125 Implied Shares Outstanding 13 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 32520 Average Volume10days 32520
Total Cash 19 M Next Fiscal Year End 1 B Held Percent Insiders 0.1748
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Share Holder Rights Risk 8 Regular Market Previous Close 3.39 Target Low Price 15.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 3.91 Open 3.38
Free Cashflow -12449000 State CA Dividend Yield 0.00 %
Return On Assets -0.6492 Time Zone Short Name EST Board Risk 8
Trailing Eps -1.11 Day Low 3.38 Address1 505 Coast Boulevard South
Shares Outstanding 13 M Compensation Risk 9 Price Hint 4
Target High Price 20.00 Website https://www.calcimedica.com 52 Week Change -0.1711
Average Volume 55745 Forward Eps -1.63 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 488.90 % Is_sp_500 False
Regular Market Day High 3.49 Profit Margins 0.00 % Fifty Two Week High 8.38
Day High 3.49 Shares Short 72576 Regular Market Open 3.38
Industry Key biotechnology Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0068 Operating Cashflow -19690000 Currency USD
Time Zone Full Name America/New_York Market Cap 46 M Is_nasdaq_100 False
Zip 92037 Quote Type EQUITY Industry Biotechnology
Long Name CalciMedica, Inc. Overall Risk 9 Regular Market Day Low 3.38
Held Percent Institutions 0.4387 Current Price 3.44 Address2 Suite 307
Enterprise To Ebitda -0.7990 Financial Currency USD Current Ratio 5.22
Industry Disp Biotechnology Number Of Analyst Opinions 3 Country United States
Float Shares 5 M Two Hundred Day Average 4.45 Governance Epoch Date 1 B
Enterprise Value 17 M Forward PE -2.11 Regular Market Volume 22439
Ebitda -21388000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage.

The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated (CRAC) channel inhibitors, which is in phase 2 clinical trials for the treatment of acute pancreatitis, asparaginase induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia.

It also develops CM6336, an oral CRAC channel inhibitors for chronic inflammatory indications; and Auxora, for the treatment of acute ulcerative colitis and allergic asthma.

The company is based in La Jolla, California.